TS analysis revealed conserved tissue architecture across CP response groups, whereas CS mapping revealed pretreatment metabolic reprogramming (rather than proliferation) as the defining feature of chemo‐resistant tumours, challenging current resistance paradigms. The gene discussed is CP; the disease is neoplasm.